🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
SAFIR PI3K is an open-label multicenter phase II randomized trial, comparin...
Status
Terminated
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2018-03-15
Trial ID
NCT03386162
Treatments Being Tested
Men and post- or induced menopausal women with ER\[+\] and/or PgR\[+\], HER...
Status
Completed
Location
Hospital General Universitario de Alicante
Start Date
2020-10-23
Trial ID
NCT04300790
Treatments Being Tested
To characterize the pharmacokinetics and safety of alpelisib in subjects wi...
Status
Completed
Location
DaVita Clinical Research-Denver
Start Date
2015-12-21
Trial ID
NCT02624557
Treatments Being Tested
Primary objective is to define the maximum tolerated dose (MTD) for the com...
Status
Completed
Location
Bascom Palmer Eye Institute of University Of Miami Medical Center
Start Date
2014-11-19
Trial ID
NCT02273219
The purpose of this study is to complement Study CBYL719C2301 (SOLAR-1) and...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2021-12-17
Trial ID
NCT05038735
Treatments Being Tested
This is a Phase 3, open-label, randomized, clinical trial evaluating the ef...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-12-08
Trial ID
NCT05501886
Treatments Being Tested
The purpose of the study was to determine whether treatment with a PI3K inh...
Status
Completed
Location
University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
Start Date
2014-03-11
Trial ID
NCT01923168
Treatments Being Tested
Alpelisib (BYL719) is a PIK3CA-specific inhibitor, which was developed by N...
Status
Unknown
Location
Seoul National University Bundang Hospital
Start Date
2020-09-01
Trial ID
NCT04526470
Treatments Being Tested
This is a multicenter, Phase 1b/2 trial in participants with estrogen recep...
Status
Active Not Recruiting
Location
Dothan Hematology and Oncology
Start Date
2023-01-24
Trial ID
NCT05563220
Treatments Being Tested